Blog

NIH-funded study provides roadmap for using CRISPR to investigate neurological disorders – pharmabiz.com

NIH-funded study provides roadmap for using CRISPR to investigate neurological disorders
pharmabiz.com
NIH-funded researchers at Stanford University used the gene editing tool CRISPR-Cas9 to rapidly identify genes in the human genome that might modify the severity of amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) caused by

2018-03-14 NEWS
About Michael Zand

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.